• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习辅助分析上皮间质转化通路在卵巢癌中的预后分层和免疫浸润评估。

Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.

机构信息

Department of Gynecology, Cangzhou Central Hospital, Cangzhou, Hebei, China.

出版信息

Front Endocrinol (Lausanne). 2023 Jun 19;14:1196094. doi: 10.3389/fendo.2023.1196094. eCollection 2023.

DOI:10.3389/fendo.2023.1196094
PMID:37404304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10317337/
Abstract

BACKGROUND

Ovarian cancer is the most lethal gynaecological malignancy, and serous ovarian cancer (SOC) is one of the more important pathological subtypes. Previous studies have reported a significant association of epithelial tomesenchymal transition (EMT) with invasive metastasis and immune modulation of SOC, however, there is a lack of prognostic and immune infiltration biomarkers reported for SOC based on EMT.

METHODS

Gene expression data for ovarian cancer and corresponding patient clinical data were collected from the TCGA database and the GEO database, and cell type annotation and spatial expression analysis were performed on single cell sequencing data from the GEO database. To understand the cell type distribution of EMT-related genes in SOC single-cell data and the enrichment relationships of biological pathways and tumour functions. In addition, GO functional annotation analysis and KEGG pathway enrichment analysis were performed on mRNAs predominantly expressed with EMT to predict the biological function of EMT in ovarian cancer. The major differential genes of EMT were screened to construct a prognostic risk prediction model for SOC patients. Data from 173 SOC patient samples obtained from the GSE53963 database were used to validate the prognostic risk prediction model for ovarian cancer. Here we also analysed the direct association between SOC immune infiltration and immune cell modulation and EMT risk score. and calculate drug sensitivity scores in the GDSC database.In addition, we assessed the specific relationship between GAS1 gene and SOC cell lines.

RESULTS

Single cell transcriptome analysis in the GEO database annotated the major cell types of SOC samples, including: T cell, Myeloid, Epithelial cell, Fibroblast, Endothelial cell, and Bcell. cellchat revealed several cell type interactions that were shown to be associated with EMT-mediated SOC invasion and metastasis. A prognostic stratification model for SOC was constructed based on EMT-related differential genes, and the Kapan-Meier test showed that this biomarker had significant prognostic stratification value for several independent SOC databases. The EMT risk score has good stratification and identification properties for drug sensitivity in the GDSC database.

CONCLUSIONS

This study constructed a prognostic stratification biomarker based on EMT-related risk genes for immune infiltration mechanisms and drug sensitivity analysis studies in SOC. This lays the foundation for in-depth clinical studies on the role of EMT in immune regulation and related pathway alterations in SOC. It is also hoped to provide effective potential solutions for early diagnosis and clinical treatment of ovarian cancer.

摘要

背景

卵巢癌是最致命的妇科恶性肿瘤,浆液性卵巢癌(SOC)是其中一个重要的病理亚型。先前的研究表明上皮间质转化(EMT)与 SOC 的侵袭转移和免疫调节密切相关,然而,目前尚无基于 EMT 的 SOC 预后和免疫浸润生物标志物的报道。

方法

从 TCGA 数据库和 GEO 数据库中收集卵巢癌的基因表达数据和相应的患者临床数据,并对 GEO 数据库中的单细胞测序数据进行细胞类型注释和空间表达分析。为了了解 EMT 相关基因在 SOC 单细胞数据中的细胞类型分布以及生物途径和肿瘤功能的富集关系。此外,对 EMT 主要表达的 mRNAs 进行 GO 功能注释分析和 KEGG 通路富集分析,以预测 EMT 在卵巢癌中的生物学功能。筛选 EMT 的主要差异基因,构建 SOC 患者的预后风险预测模型。使用从 GSE53963 数据库中获得的 173 个 SOC 患者样本数据对该模型进行验证。在这里,我们还分析了 SOC 免疫浸润与免疫细胞调节和 EMT 风险评分之间的直接关联,并在 GDSC 数据库中计算了药物敏感性评分。此外,我们评估了 GAS1 基因与 SOC 细胞系之间的特定关系。

结果

GEO 数据库中的单细胞转录组分析注释了 SOC 样本的主要细胞类型,包括:T 细胞、髓样细胞、上皮细胞、成纤维细胞、内皮细胞和 B 细胞。cellchat 揭示了几种细胞类型的相互作用,这些相互作用与 EMT 介导的 SOC 侵袭和转移有关。基于 EMT 相关差异基因构建 SOC 的预后分层模型,Kapan-Meier 检验表明该标志物对几个独立的 SOC 数据库具有显著的预后分层价值。EMT 风险评分在 GDSC 数据库中对药物敏感性具有良好的分层和识别特性。

结论

本研究构建了一个基于 EMT 相关风险基因的 SOC 免疫浸润机制和药物敏感性分析的预后分层生物标志物。这为 EMT 在 SOC 免疫调节和相关通路改变中的作用的深入临床研究奠定了基础。也希望为卵巢癌的早期诊断和临床治疗提供有效的潜在解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/a723e9fa856f/fendo-14-1196094-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/cdf3c7d7a208/fendo-14-1196094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/f8661a4ecf12/fendo-14-1196094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/60c4104c7ec6/fendo-14-1196094-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/3cfe4266437a/fendo-14-1196094-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/7f38e7de9981/fendo-14-1196094-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/4bc75564f291/fendo-14-1196094-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/ae4f9e263c30/fendo-14-1196094-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/a723e9fa856f/fendo-14-1196094-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/cdf3c7d7a208/fendo-14-1196094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/f8661a4ecf12/fendo-14-1196094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/60c4104c7ec6/fendo-14-1196094-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/3cfe4266437a/fendo-14-1196094-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/7f38e7de9981/fendo-14-1196094-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/4bc75564f291/fendo-14-1196094-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/ae4f9e263c30/fendo-14-1196094-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ca/10317337/a723e9fa856f/fendo-14-1196094-g008.jpg

相似文献

1
Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.机器学习辅助分析上皮间质转化通路在卵巢癌中的预后分层和免疫浸润评估。
Front Endocrinol (Lausanne). 2023 Jun 19;14:1196094. doi: 10.3389/fendo.2023.1196094. eCollection 2023.
2
Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.上皮性卵巢癌铂耐药:上皮-间充质转化的相互作用与重编程代谢相关联。
J Transl Med. 2022 Dec 3;20(1):556. doi: 10.1186/s12967-022-03776-y.
3
CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer.CST2 通过激活浆液性卵巢癌细胞中的 Wnt-β-连环蛋白信号通路促进细胞增殖并调节细胞周期。
J Obstet Gynaecol. 2024 Dec;44(1):2363515. doi: 10.1080/01443615.2024.2363515. Epub 2024 Jun 12.
4
Defining three ferroptosis-based molecular subtypes and developing a prognostic risk model for high-grade serous ovarian cancer.定义三种基于铁死亡的分子亚型,并为高级别浆液性卵巢癌开发一种预后风险模型。
Aging (Albany NY). 2024 May 24;16(10):9106-9126. doi: 10.18632/aging.205857.
5
Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/-Catenin-Mediated EMT and Tumour Metastasis.富含半胱氨酸的肠内蛋白 1 通过促进 Wnt/-连环蛋白介导的 EMT 和肿瘤转移,作为卵巢癌的上皮标志物。
Dis Markers. 2021 Aug 6;2021:3566749. doi: 10.1155/2021/3566749. eCollection 2021.
6
Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.赖氨酸去甲基化酶 2A 通过调节 PI3K 通路和逆转上皮-间充质转化促进卵巢癌的进展。
Oncol Rep. 2019 Feb;41(2):917-927. doi: 10.3892/or.2018.6888. Epub 2018 Nov 27.
7
Prognostic risk factors of serous ovarian carcinoma based on mesenchymal stem cell phenotype and guidance for therapeutic efficacy.基于间充质干细胞表型的浆液性卵巢癌预后风险因素及治疗效果评估。
J Transl Med. 2023 Jul 11;21(1):456. doi: 10.1186/s12967-023-04284-3.
8
Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development.整合分析揭示了 ECM 特征和驱动肝细胞癌进展的途径:一种多组学方法和预后模型的开发。
J Cell Mol Med. 2024 Apr;28(8):e18230. doi: 10.1111/jcmm.18230.
9
Identification of immunity- and ferroptosis-related genes for predicting the prognosis of serous ovarian cancer.鉴定免疫和铁死亡相关基因,预测浆液性卵巢癌的预后。
Gene. 2022 Sep 5;838:146701. doi: 10.1016/j.gene.2022.146701. Epub 2022 Jun 28.
10
Effect of ubiquitin-specific proteinase 43 on ovarian serous adenocarcinoma and its clinical significance.泛素特异性蛋白酶 43 对卵巢浆液性腺癌的影响及其临床意义。
J Obstet Gynaecol. 2024 Dec;44(1):2361862. doi: 10.1080/01443615.2024.2361862. Epub 2024 Jun 25.

引用本文的文献

1
Leveraging machine learning models to evaluate immune infiltration in the ovarian cancer microenvironment: a single-cell analysis approach.利用机器学习模型评估卵巢癌微环境中的免疫浸润:一种单细胞分析方法。
Discov Oncol. 2025 Jul 9;16(1):1291. doi: 10.1007/s12672-025-03018-9.
2
From Defense to Disease: How the Immune System Fuels Epithelial-Mesenchymal Transition in Ovarian Cancer.从防御到疾病:免疫系统如何助力卵巢癌中的上皮-间质转化
Int J Mol Sci. 2025 Apr 24;26(9):4041. doi: 10.3390/ijms26094041.
3
Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers.

本文引用的文献

1
Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.单细胞 RNA 测序揭示了人类高级别浆液性卵巢癌中的组织架构。
Clin Cancer Res. 2022 Aug 15;28(16):3590-3602. doi: 10.1158/1078-0432.CCR-22-0296.
2
Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial-Mesenchymal Transition in Recurrent Bladder Cancer.单细胞分析揭示复发性膀胱癌中癌症干细胞维持和上皮-间充质转化的机制。
Clin Cancer Res. 2021 Nov 15;27(22):6265-6278. doi: 10.1158/1078-0432.CCR-20-4796. Epub 2021 Sep 15.
3
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy.
高级别浆液性卵巢癌中的肿瘤异质性概述。
Int J Mol Sci. 2023 Oct 11;24(20):15077. doi: 10.3390/ijms242015077.
FGFR2 信号的激活抑制了 BRCA1 的表达,并驱动三阴性乳腺癌的发生,而这种肿瘤对免疫治疗敏感。
Adv Sci (Weinh). 2021 Nov;8(21):e2100974. doi: 10.1002/advs.202100974. Epub 2021 Sep 13.
4
Ovarian Cancer Immunotherapy and Personalized Medicine.卵巢癌免疫治疗与个性化医学。
Int J Mol Sci. 2021 Jun 18;22(12):6532. doi: 10.3390/ijms22126532.
5
RAF-MEK-ERK pathway in cancer evolution and treatment.RAF-MEK-ERK 通路在癌症演进和治疗中的作用。
Semin Cancer Biol. 2022 Oct;85:123-154. doi: 10.1016/j.semcancer.2021.05.010. Epub 2021 May 13.
6
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.粪便微生物移植克服了黑色素瘤患者对抗 PD-1 治疗的耐药性。
Science. 2021 Feb 5;371(6529):595-602. doi: 10.1126/science.abf3363.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.大肠杆菌 Nissle 1917 的应用可改善伊立替康诱导的小鼠肠道屏障功能障碍和肠道微生物失调。
Life Sci. 2019 Aug 15;231:116529. doi: 10.1016/j.lfs.2019.06.004. Epub 2019 Jun 4.
9
Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.自噬与上皮-间质转化的串扰及其在癌症治疗中的应用。
Mol Cancer. 2019 May 24;18(1):101. doi: 10.1186/s12943-019-1030-2.
10
Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.上皮-间充质可塑性在癌症进展和转移中的作用。
Dev Cell. 2019 May 6;49(3):361-374. doi: 10.1016/j.devcel.2019.04.010.